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General Methods. Melting points were determined with a hot-stage apparatus and are
uncorrected. Optical rotations were measured at the sodium line at ambient temperature in CHCl3
solutions. IR spectra were recorded in CHCl3 solutions unless otherwise stated. NMR spectra were
determined at 500 MHz for 1H and 125.7 MHz for 13C in CDCl3 unless otherwise stated, in the
presence of TMS as internal standard. Mass spectra were determined at 70 eV. Merck silica gel 60
PF (0.063–0.2 mm) was used for column chromatography. Circular layers of 1 mm of Merck silica
gel 60 PF254 were used on a Chromatotron for centrifugally assisted chromatography.
Commercially available reagents and solvents were analytical grade or were purified by standard
procedures prior to use. All reactions involving air- or moisture-sensitive materials were carried out
under a nitrogen atmosphere. The spray reagents for TLC analysis were conducted with 0.5%
vanillin in H2SO4–EtOH (4:1) and further heating until development of color.
Orthoacetate (2). To a solution of methyl 2,3-di-O-acetyl-4-O-(2,3,4,6-tetra-O-acetyl-α-D-
glucopyranosyl)-β-D-glucopyranoside (1)[1] (85 mg, 0.139 mmol) in dry CH2Cl2 (6 mL) were added
(diacetoxyiodo)benzene (67 mg, 0.21 mmol), and iodine (24 mg, 0.098 mmol) and the reaction was
stirred at 25 oC for 90 min under irradiation with two 100W tungsten filament lamps. The reaction
mixture was then poured into aqueous 10% Na2S2O3 and extracted with CH2Cl2. The organic layer
2was washed with brine, dried (Na2SO4) and concentrated under reduced pressure. The residue was
purified by column chromatography (hexanes–EtOAc, 6:4) to give compound 2 (52 mg, 0.086
mmol, 62%) as a crystalline solid: mp double 195.5–196.5 and 210.3–211.5 oC (from n-pentane–
EtOAc); [α]D = –3 (c = 0.22): IR 1754 cm–1; 1H NMR (CDCl3, 500 MHz) 1.56 (3H, s), 2.01 (6H,
s), 2.02 (6H, s), 2.07 (3H, s), 3.47 (3H, s), 3.56 (1H, br d, J = 9.7 Hz), 3.74 (1H, d, J = 9.0 Hz), 4.02
(1H, br dd, J = 11.7, 2.5 Hz), 4.10 (1H, br dd, J = 9.2, 3.1 Hz), 4.18 (1H, d, J = 9.1 Hz), 4.18 (1H,
m), 4.38 (1H, d, J = 8.1 Hz), 4.81 (1H, dd, J = 8.6, 8.6 Hz), 4.89 (1H, dd, J = 10.4, 5.3 Hz), 5.07
(1H, d, J = 10.2 Hz), 5.21 (1H, dd, J = 9.4, 9.4 Hz), 5.43 (1H, d, J = 5.1 Hz), 5.74 (1H, dd, J = 10.2,
10.2 Hz); 1H NMR (C6D6, 500 MHz) 1.47 (3H, s), 1.61 (3H, s), 1.64 (3H, s), 1.73 (3H, s), 1.88
(3H, s), 1.91 (3H, s), 3.15 (3H, s), 3.20 (1H, d, J = 10.6 Hz), 3.60 (1H, d, J = 9.2 Hz), 3.79 (1H, dd,
J = 12.8, 2.8 Hz), 3.95 (2H, m), 3.96 (1H, d, J = 8.5 Hz), 4.13 (1H, d, J = 7.8 Hz), 4.93 (1H, dd, J =
10.6, 5.0 Hz), 5.06 (1H, dd, J = 9.2, 9.2 Hz), 5.09 (1H, d, J = 9.9 Hz), 5.33 (1H, d, J = 5.0 Hz), 5.36
(1H, dd, J = 9.2, 9.2 Hz), 6.14 (1H, dd, J = 10.2, 10.2 Hz); 13C NMR (CDCl3, 125.7 MHz) 20.3
(CH3), 20.4 (CH3), 20.5 (CH3), 20.6 (CH3), 21.0 (CH3), 22.5 (CH3), 56.7 (CH3), 64.2 (CH2), 66.9
(CH), 68.0 (CH), 70.3 (CH), 72.4 (CH2), 72.6 (CH), 73 (br, CH), 74.7 (CH), 75.2 (CH), 96.0 (CH),
101.3 (CH), 103.1 (C), 124.8 (C), 169.4 (C), 169.6 (C), 169.8 (C), 170.3 (C), 170.5 (C); 13C NMR
(C6D6, 125.7 MHz) 19.9 (CH3), 20.1 (CH3), 20.2 (CH3), 20.4 (CH3), 20.9 (CH3), 23.0 (CH3), 56.0
(CH3), 65.0 (CH2), 67.5 (CH), 68.5 (CH), 70.8 (CH), 72.5 (CH2), 72.8 (CH), 74 (br, CH), 75.5
(CH), 75.8 (CH), 96.8 (CH), 101.4 (CH), 103.5 (C), 125.4 (C), 169.0 (C), 169.1 (C), 169.4 (C),
170.3 (2 × C); MS FAB (rel intensity) 629 (M+ + Na, 27), 607 (100), 575(68); HRMS calcd for
C25H34O17Na 629.169370, found 629.166656. Anal. Calcd for C25H34O17: C, 49.51; H, 5.65. Found:
C, 49.52; H, 5.81.
3Compound 2
Crystal data and structure refinement for compound 2.
Empirical formula C25H34O17
Formula weight 606.52
Temperature 150 (2) K
Wavelength 0.71073 Å
Crystal system, space group Monoclinic, P21
Unit cell dimensions a = 6.5670 (2), b = 14.4480 (6), c = 15.6960 (6) Å
α = 90, β = 101.754 (3), γ = 90o
Volume 1458.01 (9) Å3
Z, Calculated density 2,   1.382 Mg/m3
Absorption coefficient 0.118 mm–1
F(000) 640
Crystal size 0.80 × 0.20 × 0.15 mm
Theta range for data collection 1.93 to 24.98 deg.
Index ranges 0<=h<=7,   –17<=k<=17,   –18<=l<=18
Reflections collected / unique 5103 / 5103 [R(int) = 0.0000]
Completeness to 2θ = 24.98 99.7%
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4Absorption correction None
Max. And min. transmission 0.9825 and 0.9114
Refinement method Full-matrix least-squares on F2
Data  /  restraints  /  parameters 5103  /  1  /  385
Goodness-of-fit on F2 1.077
Final R indices [I>2σ (I)] R1 = 0.0618, wR2 = 0.1023
R indices (all data) R1 = 0.1077, wR2 = 0.1184
Absolute structure parameters 1.1 (13)
Largest diff. peak and hole 0.290 and – 0.286 e.Å–3
2,3,4,6-Tetra-O-acetyl-α-D-gluco-hexopyranoside-5-ulose (Methyl 2,3-Di-O-acetyl-α-D-
glucopyranose) 5,6’:1,4’-Dianhydride (3). A solution of orthoacetate 2 (15 mg, 0.025 mmol) in
CDCl3 (0.5 mL) was kept at room temperature for 60 h. Concentration under reduced pressure
afforded the title compound 3 in quantitative yield as a syrup: [α]D = –14.5 (c = 0.22); IR 1748 cm–
1; 1H NMR (CDCl3, 500 MHz) 2.00 (6H, s), 2.01 (3H, s), 2.02 (3H, s), 2.06 (3H, s), 2.10 (3H, s),
3.43 (1H, d, J = 9.1 Hz), 3.47 (3H, s), 3.85 (1H, d, J = 11.7 Hz), 3.87 (1H, d, J = 11.7 Hz), 4.08
(1H, d, J = 11.2 Hz), 4.14 (1H, d, J = 11.7 Hz), 4.29 (1H, dd, J = 9.6, 9.6 Hz), 4.43 (1H, d, J = 7.6
Hz), 4.78 (1H, dd, J = 8.6, 8.6 Hz), 4.91 (1H, dd, J = 10.7, 5.1 Hz), 5.13 (1H, d, J = 9.7 Hz), 5.22
(1H, dd, J = 9.6, 9.6 Hz), 5.61 (1H, d, J = 4.5 Hz), 5.76 (1H, dd, J = 10.2, 10.2 Hz); 13C NMR
(CDCl3, 125.7 MHz) 20.4 (CH3), 20.5 (CH3), 20.6 (2 × CH3), 20.7 (CH3), 21.0 (CH3), 57.2 (CH3),
60.5 (CH2), 65.6 (CH), 65.6 (CH2), 68.7 (CH), 69.6 (CH), 70.2 (CH), 72.4 (CH), 74.4 (CH), 75.5
(CH), 95.1 (CH), 96.5 (C), 101.7 (CH), 169.6 (2 × C), 169.7 (C), 170.3 (C), 170.4 (C), 170.5 (C);
MS (rel intensity) 591 (M+ – Me, <1), 546 (<1), 533 (11), 505 (5), 491 (9); HRMS calcd for
C24H31O17 591.156125, found 591.150742. Anal. Calcd for C25H34O17: C, 49.51; H, 5.65. Found: C,
49.58; H, 5.37.
2,3,4,6-Tetra-O-methyl-α-D-gluco-hexopyranoside-5-ulose (Methyl 2,3-Di-O-methyl-β-D-
glucopyranose) 5,6’:1,4’-Dianhydride (5) To a solution of methyl 2,3-di-O-methyl-4-O-(2,3,4,6-
5tetra-O-methyl-α-D-glucopyranosyl)-β-D-glucopyranoside (4)[2] (52 mg, 0.118 mmol) in dry
CH2Cl2 (6 mL) were added (diacetoxyiodo)benzene (64 mg, 0.199 mmol), and iodine (16 mg, 0.063
mmol) and the reaction was stirred at 25 oC for 90 min. The reaction mixture was then poured into
aqueous 10% Na2S2O3 and extracted with CH2Cl2. The organic layer was washed with brine, dried
(Na2SO4) and concentrated under reduced pressure. The residue was purified by column
chromatography (hexanes–EtOAc, 4:6) to give compound 5 (29 mg, 0.066 mmol, 56%) as a syrup:
[α]D = +45.5 (c = 0.83); IR 2935, 2840, 1082 cm–1; 1H NMR (CDCl3, 500 MHz) 2.93 (1H, dd, J =
7.8, 9.1 Hz), 3.25 (1H, dd, J = 9.1, 9.1 Hz), 3.26 (1H, dd, J = 3.8, 9.3 Hz), 3.32 (1H, ddd, J = 4.0,
9.7, 9.7 Hz), 3.40 (3H, s), 3.41 (1H, d, J = 8.8 Hz), 3.47 (1H, d, J = 9.7 Hz), 3.488 (3H, s) 3.49 (1H,
d, J = 7.9 Hz), 3.493 (3H, s), 3.55 (3H, s), 3.55 (1H, dd, J = 9.3, 9.3 Hz), 3.59 (3H, s), 3.62 (3H, s),
3.65 (3H, s), 3.78 (1H, dd, J = 9.6, 9.6 Hz), 3.83 (1H, dd, J = 4.3, 11.9 Hz), 3.91 (1H, dd, J = 10.0,
11.5 Hz), 4.15 (1H, d, J = 7.8 Hz), 5.20 (1H, d, J = 3.4 Hz); 1H NMR (C6D6, 500 MHz) 3.25 (3H,
s), 3.25 (1H, dd, J = 8.4, 8.4 Hz), 3.31 (1H, dd, J = 3.5, 9.5 Hz), 3.33 (3H, s), 3.34 (3H, s), 3.36
(1H, ddd, J = 4.1, 9.7, 9.7 Hz), 3.39 (1H, dd, J = 9.2, 9.2 Hz), 3.42 (1H, d, J = 10.1 Hz), 3.62 (1H,
d, J = 10.2 Hz), 3.66 (3H, s), 3.72 (3H, s), 3.76 (3H, s), 3.77 (1H, dd, J = 9.4, 9.4 Hz), 3.78 (3H, s),
3.84 (1H, d, J = 9.6 Hz), 3.98 (1H, dd, J = 4.0, 11.5 Hz), 4.09 (1H, dd, J = 10.8, 10.8 Hz), 4.16 (1H,
d, J = 7.7 Hz), 4.32 (1H, dd, J = 9.6, 9.6 Hz), 5.27 (1H, d, J = 3.3 Hz); 13C NMR (CDCl3, 125.7
MHz) 57.0 (CH3), 58.0 (CH3), 59.3 (CH3), 60.5 (CH3), 60.9 (CH3), 61.1 (CH3), 61.5 (CH3), 64.5
(CH2), 69.7 (CH), 71.4 (CH2), 79.1 (2 × CH), 80.5 (CH), 81.3 (CH), 83.7 (CH), 83.8 (CH), 97.1
(CH), 101.2 (C), 104.4 (CH); MS (rel intensity) 438 (M+, 1), 393 (9), 365 (79) 350 (45), 277 (32),
233 (95); HRMS calcd for C19H34O11 438.210112, found 438.208839. Anal. Calcd for C19H34O11:
C, 52.05; H, 7.82. Found: C, 52.13; H, 8.19.
Methyl 2,3-Di-O-methyl-6-O-phthalimido-4-O-(2,3,4,6-tetra-O-methyl-α-D-
glucopyranosyl)-α-D-glucopyranoside (6). DEAD (343 µL, 2.18 mmol) was added dropwise to a
stirred solution of the methyl 2,3-di-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-α-D-glucopyranosyl)-β-
6D-glucopyranoside (4) (240 mg, 0.545 mmol), N-hydroxyphthalimide (355 mg, 2.18 mmol) and
PPh3 (571 mg, 2.18 mmol) in dry THF (6 mL) and the resulting solution was stirred at 0 oC for 0.5
h. The reaction was quenched with water and extracted with CHCl3. The combined extracts were
washed with water, dried over Na2SO4 and concentrated under reduced pressure. The obtained
residue was purified by column chromatography (benzene–EtOAc, 6:4) to give compound 6 (263
mg, 0.449 mmol, 82%) as a syrup: [α]D = +88 (c = 2.6); IR 1734 cm–1; 1H NMR (CDCl3, 500
MHz) 2.98 (1H, dd, J = 8.7, 8.7 Hz), 3.15 (1H, dd, J = 3.7, 9.8 Hz), 3.19 (1H, dd, J = 9.7, 9.7 Hz),
3.31 (3H, s), 3.34 (3H, s), 3.37 (1H, dd, J = 9.0, 9.0 Hz), 3.37 (1H, dd, J = 9.0, 9.0 Hz), 3.50 (3H,
s), 3.51 (3H, s), 3.51 (3H, s), 3.54 (3H, m), 3.55 (3H, s), 3.59 (3H, s), 3.71 (1H, dd, J = 9.0, 9.0
Hz), 3.76 (1H, dd, J = 6.5, 10.0 Hz), 4.14 (1H, d, J = 7.7 Hz), 4.30 (1H, dd, J = 6.3, 12.5 Hz), 4.51
(1H, d, J = 12.5 Hz), 5.49 (1H, d, J = 3.9 Hz), 7.71 (2H, m), 7.79 (2H, m); 13C NMR (CDCl3, 125.7
MHz) 56.7 (CH3), 59.1 (CH3), 59.4 (CH3), 59.7 (CH3), 60.1 (CH3), 60.3 (CH3), 60.7 (CH3), 70.7
(CH2), 71.0 (CH), 73.5 (CH), 73.6 (CH), 76.8 (CH2), 79.1 (CH), 81.5 (CH), 83.0 (CH), 83.5 (CH),
85.7 (CH), 97.1 (CH), 103.8 (CH), 123.3 (2 × CH), 128.9 (2 × C), 134.3 (2 × C), 163.3 (2 × C); MS
(rel intensity) 586 (M+ + 1, <1), 554 (<1), 522 (<1), 490 (<1), 410 (6); HRMS calcd for
C27H40NO13 586.2499405, found 586.2489674. Anal. Calcd for C27H39NO13: C, 55.38; H, 6.71; N,
2.39. Found: C, 55.46; H, 6.67; N, 2.30.
Methyl 2,3-Di-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-β-L-idopyranosyl)-α-D-glucopyranoside
(8) and 2,3-Di-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-α-D-glucopyranosyl)-α-D-
glucopyranoside (4). A solution of phthalimide 6 (22 mg, 0.037 mmol) in dry benzene (0.6 mL)
were was heated to reflux with n-Bu3SnH (91 µL, 0.34 mmol) and AIBN (1 mg) for 1 h. After
cooling at room temperature the solution was concentrated under reduced pressure. The residue was
dissolved in CH3CN, washed with n-hexane and the CH3CN extracts concentrated under reduced
pressure. The residue was purified by chromatotron chromatography (EtOAc) to give compound 8
(7 mg, 0.016 mmol, 43%) and compound 4 (7 mg, 0.016 mmol, 43%). Compound 8: [α]D = +33 (c
7= 0.61); IR 3494 cm–1; 1H NMR (CHCl3, 500 MHz) 3.02 (1H, dd, J = 7.9, 9.0 Hz), 3.08 (1H, br s),
3.20 (1H, br d, J = 9.9 Hz), 3.25 (1H, dd, J = 9.2, 9.2 Hz), 3.35 (3H, s), 3.41 (3H, s), 3.42 (1H, br
s), 3.43 (3H, s), 3.46 (1H, dd, J = 3.4, 10.1 Hz), 3.49 (3H, s), 3.55 (3H, s), 3.56 (3H, s), 3.63 (3H,
s), 3.68 (1H, dd, J = 1.9, 12.7 Hz), 3.72 (1H, dd, J = 9.6, 9.6 Hz), 3.73 (1H, dd, J = 2.5, 2.5 Hz),
3.82 (1H, dd, J = 9.5, 9.5 Hz), 3.96 (1H, ddd, J = 2.0, 3.0, 8.6 Hz), 4.14 (1H, d, J = 7.7 Hz), 4.18
(1H, dd, J = 1.9, 12.7 Hz), 4.90 (1H, s); 1H NMR (C6D6, 500 MHz) 2.94 (1H, br s), 3.00 (3H, s),
3.09 (3H, s), 3.09 (1H, m), 3.12 (3H, s), 3.14 (1H, dd, J = 9.5, 8.5 Hz), 3.28 (3H, s), 3.29 (1H, dd, J
= 10.2, 8.3 Hz), 3.39 (1H, dd, J = 9.5, 4.8 Hz), 3.41 (1H, br s), 3.43 (3H, s), 3.51 (3H, s), 3.56 (1H,
br s), 3.57 (3H, s), 3.70 (1H, dd, J = 9.5, 7.6 Hz), 4.01 (1H, dd, J = 9.5, 9.5 Hz), 3.92–3.97 (2H),
4.10 (1H, d, J = 7.6 Hz), 4.31 (1H, br d), 5.18 (1H, s); 13C NMR (CDCl3, 125.7 MHz) 56.6 (CH3),
57.8 (CH3), 58.5 (CH3), 58.9 (CH3), 60.18 (CH2), 60.23 (CH3), 60.41 (CH3), 61.1 (CH3), 71.9
(CH2), 73.8 (CH), 74.6 (CH), 74.9 (CH), 75.2 (CH), 76.4 (CH), 77.1 (CH), 83.9 (CH), 86.2 (CH),
102.0 (CH), 104.2 (CH); 13C NMR (C6D6, 50.3 MHz) 56.0 (CH3), 57.09 (CH3), 57.14 (CH3), 58.4
(CH3), 59.7 (CH3), 59.9 (CH3), 60.6 (CH3), 61.6 (CH2), 71.7 (CH2), 73.8 (CH), 75.1 (CH), 75.3
(CH), 75.7 (CH), 76.78 (CH), 76.84 (CH), 84.2 (CH), 86.51 (CH), 101.33 (CH), 104.70 (CH); MS
(rel intensity) 408 (M+ – MeOH,<1), 377 (<1), 308 (4), 275 (9), 265 (45); HRMS calcd for
C18H32O10 408.199548, found 408.197708. Anal. Calcd for C19H36O11: C, 51.81; H, 8.24. Found: C,
52.07; H, 7.85.
Methyl 2,3-Di-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-β-L-idopyranosyl-5-C-2H1)-α-D-
glucopyranoside (9) and Methyl 2,3-Di-O-methyl-4-O-(2,3,4,6-tetra-O-methyl-α-D-
glucopyranosyl-5-C-2H1)-β-D-glucopyranoside (7). A solution of phthalimide 6 (29 mg, 0.049
mmol) in dry benzene (0.8 mL) was heated to reflux with n-Bu3SnD (120 µL, 0.446 mmol) and
AIBN (1.3 mg) for 1 h. After cooling at room temperature the solution was concentrated under
reduced pressure. The residue was dissolved in CH3CN, washed with n-hexane and the CH3CN
extracts concentrated under reduced pressure. The residue was purified by chromatotron
8chromatography (EtOAc) to give compound 9 (8 mg, 0.018 mmol, 37%) and compound 7 (9 mg,
0.02 mmol, 41%). Compound 9: 1H NMR (C6D6, 500 MHz) 2.95 (1H, br d, J = 2.1 Hz), 3.00 (3H,
s), 3.10 (3H, s), 3.11 (3H, s), 3.11 (1H, m), 3.14 (1H, dd, J = 7.8, 9.0 Hz), 3.28 (3H, s), 3.30 (1H,
dd, J = 9.2, 9.2 Hz), 3.39 (1H, d, J = 9.6 Hz), 3.41 (1H, br d, J = 3.2 Hz), 3.43 (3H, s), 3.51 (3H, s),
3.56 (1H, br d, J = 2.6 Hz), 3.57 (3H, s), 3.69 (1H, d, J = 9.6 Hz), 3.98 (1H, m), 4.01 (1H, dd, J =
9.5, 9.5 Hz), 4.10 (1H, d, J = 7.7 Hz), 4.32 (1H, br d, J = 11.8 Hz), 5.19 (1H, d, J = 1.3 Hz); 13C
NMR (C6D6, 125.7 MHz) 56.3 (CH3), 57.4 (CH3), 57.4 (CH3), 58.7 (CH3), 60.0 (CH3), 60.2 (CH3),
60.8 (CH3), 61.8 (CH2), 71.9 (CH2), 75.3 (CH), 75.6 (CH), 76.0 (CH), 77.0 (CH), 77.1 (CH), 84.5
(CH), 86.8 (CH), 101.6 (CH), 105.0 (CH); MS FAB (rel intensity) 464 (M+ + Na, 100), 442 (10),
307 (25), 289 (13); HRMS calcd for C19H352H1NaO11 464.221809, found 464.221153. Compound
7: (D/H ratio of 57:43) 13C NMR (C6D6, 50.3 MHz) 56.3 (CH3), 59.0 (2 × CH3), 59.9 (CH3), 60.2
(CH3), 60.3 (CH3), 60.6 (CH3), 61.8 (CH2), 72.0 (CH), 72.240 (CH2), 72.298 (CH2), 74.3 (CH),
75.5 (CH), 80.472 (CH), 80.530 (CH), 82.7 (CH), 84.1 (CH), 84.9 (CH), 86.9 (CH), 97.8 (CH),
104.6 (CH); MS FAB (rel intensity) 464 (M+ + Na, 29), 463 (M+ + Na, 21), 410 (7), 409 (6), 307
(6); HRMS calcd for C19H352H1NaO11 464.221809, found 464.222954; calcd for C19H36NaO11
463.215532, found 463.216179.
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